Cargando…
Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer
Patients with inflammatory bowel disease have an additional risk of developing cancer compared with the general population. This is due to local chronic inflammation that leads to the development of gastrointestinal cancers and the use of thiopurines, associated with a higher risk of lymphoprolifera...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hellenic Society of Gastroenterology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805731/ https://www.ncbi.nlm.nih.gov/pubmed/27065724 http://dx.doi.org/10.20524/aog.2016.0004 |